Your browser doesn't support javascript.
loading
A novel soluble complement receptor 1 fragment with enhanced therapeutic potential.
Wymann, Sandra; Dai, Yun; Nair, Anup G; Cao, Helen; Powers, Glenn A; Schnell, Anna; Martin-Roussety, Genevieve; Leong, David; Simmonds, Jason; Lieu, Kim G; de Souza, Mitchell J; Mischnik, Marcel; Taylor, Shirley; Ow, Saw Yen; Spycher, Martin; Butcher, Rebecca E; Pearse, Martin; Zuercher, Adrian W; Baz Morelli, Adriana; Panousis, Con; Wilson, Michael J; Rowe, Tony; Hardy, Matthew P.
Afiliação
  • Wymann S; Research and Development, CSL Behring AG, Bern, Switzerland.
  • Dai Y; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Nair AG; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Cao H; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Powers GA; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Schnell A; Research and Development, CSL Behring AG, Bern, Switzerland.
  • Martin-Roussety G; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Leong D; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Simmonds J; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Lieu KG; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • de Souza MJ; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Mischnik M; Research and Development, CSL Behring GmbH, Marburg, Germany.
  • Taylor S; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Ow SY; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Spycher M; Research and Development, CSL Behring AG, Bern, Switzerland.
  • Butcher RE; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Pearse M; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Zuercher AW; Research and Development, CSL Behring AG, Bern, Switzerland.
  • Baz Morelli A; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Panousis C; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Wilson MJ; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Rowe T; CSL Ltd, Bio21 Institute, Victoria, Australia.
  • Hardy MP; CSL Ltd, Bio21 Institute, Victoria, Australia. Electronic address: matt.hardy@csl.com.au.
J Biol Chem ; 296: 100200, 2021.
Article em En | MEDLINE | ID: mdl-33334893
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Complemento 3b / Ativação do Complemento Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Complemento 3b / Ativação do Complemento Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: J Biol Chem Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça